Lu, H., Yang, Y., Gad, E., Inatsuka, C., Wenner, C. A., Disis, M. L., & Standish, L. J. (2011). TLR2 agonist PSK activates human NK cells and enhances the anti-tumor effect of HER2-targeted monoclonal antibody therapy.

Lu, Hailing, Yi Yang, Ekram Gad, Carol Inatsuka, Cynthia A. Wenner, Mary L. Disis, und Leanna J. Standish. TLR2 Agonist PSK Activates Human NK Cells and Enhances the Anti-tumor Effect of HER2-targeted Monoclonal Antibody Therapy. 2011.

Lu, Hailing, et al. TLR2 Agonist PSK Activates Human NK Cells and Enhances the Anti-tumor Effect of HER2-targeted Monoclonal Antibody Therapy. 2011.